723 related articles for article (PubMed ID: 19202514)
41. Clinical results of drug eluting stents compared to bare metal stents for patients with ST elevation acute myocardial infarction.
Kornowski R; Vaknin-Assa H; Lev E; Ben-Dor I; Teplitsky I; Rechavia E; Brosh D; Fuchs S; Assali A
Acute Card Care; 2008; 10(3):167-72. PubMed ID: 18803074
[TBL] [Abstract][Full Text] [Related]
42. [Impact of drug-eluting stents on transferring treatment with coronary surgical revascularization among patients initially admitted to department of internal medicine].
He LQ; Ma CS; Nie SP; Lü Q; Jia CQ; DU X; Liu XH; Dong JZ; Li ZZ; Chen F; Zhou YJ; Lü SZ; Wu XS
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1518-22. PubMed ID: 17785099
[TBL] [Abstract][Full Text] [Related]
43. Safety and effectiveness of drug-eluting stents among diabetic patients: a propensity analysis.
Ko DT; Chiu M; Austin PC; Bowen J; Cohen EA; Tu JV
Am Heart J; 2008 Jul; 156(1):125-34. PubMed ID: 18585507
[TBL] [Abstract][Full Text] [Related]
44. Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET.
Pfisterer M; Brunner-La Rocca HP; Rickenbacher P; Hunziker P; Mueller C; Nietlispach F; Leibundgut G; Bader F; Kaiser C;
Eur Heart J; 2009 Jan; 30(1):16-24. PubMed ID: 19033260
[TBL] [Abstract][Full Text] [Related]
45. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease.
Lee MS; Kapoor N; Jamal F; Czer L; Aragon J; Forrester J; Kar S; Dohad S; Kass R; Eigler N; Trento A; Shah PK; Makkar RR
J Am Coll Cardiol; 2006 Feb; 47(4):864-70. PubMed ID: 16487857
[TBL] [Abstract][Full Text] [Related]
46. Drug-eluting stents in the elderly: long-term (> one year) clinical outcomes of octogenarians in the DESIRE (Drug-Eluting Stents In the REal world) registry.
Costa JR; Sousa A; Moreira AC; Costa RA; Maldonado G; Cano MN; Egito ET; Romano ER; Barbosa M; Pavanello R; Jardim C; Cury A; Berwanger O; Sousa JE
J Invasive Cardiol; 2008 Aug; 20(8):404-10. PubMed ID: 18688065
[TBL] [Abstract][Full Text] [Related]
47. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease.
Yang ZK; Shen WF; Zhang RY; Kong Y; Zhang JS; Hu J; Zhang Q; Ding FH
J Interv Cardiol; 2007 Feb; 20(1):10-6. PubMed ID: 17300391
[TBL] [Abstract][Full Text] [Related]
48. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
Silber S; Herdeg C
Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314
[TBL] [Abstract][Full Text] [Related]
49. Comparison of long-term results of drug-eluting stent and bare metal stent implantation in heart transplant recipients with coronary artery disease.
Zakliczynski M; Lekston A; Osuch M; Swierad M; Nadziakiewicz P; Przybylski R; Zembala M
Transplant Proc; 2007 Nov; 39(9):2859-61. PubMed ID: 18022002
[TBL] [Abstract][Full Text] [Related]
50. Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: the sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT).
Meliga E; Garcia-Garcia HM; Valgimigli M; Chieffo A; Biondi-Zoccai G; Maree AO; Gonzalo N; Cook S; Marra S; Moretti C; De Servi S; Palacios IF; Windecker S; van Domburg R; Colombo A; Sheiban I; Serruys PW
Int J Cardiol; 2009 Sep; 137(1):16-21. PubMed ID: 18687481
[TBL] [Abstract][Full Text] [Related]
51. Early outcome of treatment of ostial de novo left anterior descending coronary artery lesions with drug-eluting stents.
Tsagalou E; Stankovic G; Iakovou I; Melzi G; Cosgrave J; Ge L; Michev I; Chieffo A; Airoldi F; Carlino M; Montorfano M; Colombo A
Am J Cardiol; 2006 Jan; 97(2):187-91. PubMed ID: 16442360
[TBL] [Abstract][Full Text] [Related]
52. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease.
Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Choo SJ; Song H; Chung CH; Lee JW; Park SW; Park SJ
Circulation; 2008 Apr; 117(16):2079-86. PubMed ID: 18413495
[TBL] [Abstract][Full Text] [Related]
53. Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation.
Stone GW; Ellis SG; Colombo A; Dawkins KD; Grube E; Cutlip DE; Friedman M; Baim DS; Koglin J
Circulation; 2007 Jun; 115(22):2842-7. PubMed ID: 17515458
[TBL] [Abstract][Full Text] [Related]
54. Use of multiple overlapping sirolimus-eluting stents for treatment of long coronary artery lesions: results from a single-center registry in 318 consecutive patients.
Ruchin PE; Trabattoni D; Fabbiocchi F; Montorsi P; Lualdi A; Ravagnani P; Grancini L; Galli S; Teruzzi G; Calligaris G; De Martini S; Bartorelli AL
Int J Cardiol; 2009 May; 134(2):231-7. PubMed ID: 18582971
[TBL] [Abstract][Full Text] [Related]
55. [Comparison of drug-eluting and bare metal stents in saphenous vein grafts. Immediate and long-term results].
Lozano I; García-Camarero T; Carrillo P; Baz JA; de la Torre JM; López-Palop R; Pinar E; Salvatella N; Avanzas P; Valdés M
Rev Esp Cardiol; 2009 Jan; 62(1):39-47. PubMed ID: 19150013
[TBL] [Abstract][Full Text] [Related]
56. Stent implantation for the unprotected left main coronary artery. The long-term outcome of 62 patients.
Peszek-Przybyła E; Buszman P; Białkowska B; Zurakowski L; Banasiewicz-Szkróbka I; Debiński M; Tendera M
Kardiol Pol; 2006 Jan; 64(1):1-6; discussion 7. PubMed ID: 16444619
[TBL] [Abstract][Full Text] [Related]
57. Long-term outcomes following drug-eluting stent implantation in unprotected left main bifurcation lesions.
Ge L; Cosgrave J; Iakovou I; Qian JY; Agostoni P; Sangiorgi GM; Airoldi F; Michev I; Chieffo A; Corvaja N; Colombo A; Ge JB
Chin Med J (Engl); 2007 Apr; 120(7):545-51. PubMed ID: 17442200
[TBL] [Abstract][Full Text] [Related]
58. Comparison of bare-metal and sirolimus- or paclitaxel-eluting stents for aorto-ostial coronary disease.
Barlis P; Kaplan S; Dimopoulos K; Ferrante G; Di Mario C
Cardiology; 2008; 111(4):270-6. PubMed ID: 18451644
[TBL] [Abstract][Full Text] [Related]
59. Long-term clinical outcomes of the Drug-Eluting Stents in the Real World (DESIRE) Registry.
Sousa A; Costa JR; Moreira AC; Cano M; Maldonado G; Costa RA; Pavanello R; Romano ER; Campos C; Haddad N; Abizaid A; Feres F; Mattos LA; Staico R; Sousa JE;
J Interv Cardiol; 2008 Aug; 21(4):307-14. PubMed ID: 18754966
[TBL] [Abstract][Full Text] [Related]
60. Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings.
Aoki J; Kirtane AJ; Dangas GD; Lansky AJ; Morales A; Kimura M; Kim YH; Moussa I; Weisz G; Kreps EM; Collins M; Frankin-Bond T; Stone GW; Moses JW; Leon MB; Mehran R
Am J Cardiol; 2008 Jan; 101(1):58-62. PubMed ID: 18157966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
